Clinical Trial Update: Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 trial in Korea comparing low-dose rosuvastatin plus ezetimibe versus high-dose rosuvastatin alone in patients with minimal to intermediate coronary arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Dyslipidemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: Saint Vincent's Hospital, Korea | Conditions: Coronary Artery Disease, Dyslipidemias | Phase 4 | Status: RECRUITING